New Hepatitis C Treatment Approved by FDA: Mavyret

1
New Hepatitis C Treatment Approved by FDA Mavyret
2

• Mavyret is used to treat hepatitis C by AbbVie.
• Mavyret is an 8 week treatment for all genotypes
  of hepatitis C.
• Mavyret cost for, 8 week course, 56 tablets is
  only 26,400.For 12 weeks treatment 39,600, 16
  weeks treatment 52,800.
• Mavyret is more affordable than Sovaldi, Harvoni,
  Epclusa and Daklinza.

3

• AbbVie will focus on getting insurers to only
  provide Mavyret rather than the competitors. It
  will do this by providing 50 off on treatment
  costs.
• AbbVie will also focus on getting coverage for
  Medicare, Medicaid and the Veterans
  Administration.
• Clinical study show for Mavyret that 97.5 of
  adult patients are cured, only those without
  cirrhosis. 98 of those with kidney damage were
  cured after 12 weeks of treatment.

4

• Mavyret is made up of two hepatitis C treatments
  glecaprevir and pibrentasvir, taken as three
  pills together once a day.
• Mavyret side effects were nausea, fatigue,
  headache and itchy skin.
• Hepatitis B patients that also have hepatitis C
  that take Mavyret can reactivate that virus
  causing fatal liver damage.

5
http//www.sunnypharma.org

• Just give us call a call at 
• 1-858-952-1077
• 91 88263 25543
• hcvmeds_at_gmail.com